|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-11-30
|
|
pubmed:abstractText |
Altered serotonergic and dopaminergic function have been widely implicated in behavioural disorders associated with impulsivity and risk-taking. However, little research has addressed the specific cognitive consequences of changed monoaminergic function that might contribute to the production of impulsive behaviour.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0033-3158
|
|
pubmed:author |
pubmed-author:BlackshawA JAJ,
pubmed-author:CrowleyCC,
pubmed-author:DeakinJ FJF,
pubmed-author:HawtinKK,
pubmed-author:HopwoodAA,
pubmed-author:MatthewsKK,
pubmed-author:MiddletonH CHC,
pubmed-author:RobbinsT WTW,
pubmed-author:RogersR DRD,
pubmed-author:SahakianB JBJ,
pubmed-author:WallaceCC
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
146
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
482-91
|
|
pubmed:dateRevised |
2009-9-29
|
|
pubmed:meshHeading |
pubmed-meshheading:10550499-Adolescent,
pubmed-meshheading:10550499-Adrenergic Agents,
pubmed-meshheading:10550499-Adult,
pubmed-meshheading:10550499-Attention,
pubmed-meshheading:10550499-Clonidine,
pubmed-meshheading:10550499-Discrimination Learning,
pubmed-meshheading:10550499-Double-Blind Method,
pubmed-meshheading:10550499-Female,
pubmed-meshheading:10550499-Humans,
pubmed-meshheading:10550499-Impulsive Behavior,
pubmed-meshheading:10550499-Male,
pubmed-meshheading:10550499-Methylphenidate,
pubmed-meshheading:10550499-Reward,
pubmed-meshheading:10550499-Tryptophan
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour.
|
|
pubmed:affiliation |
Departments of Experimental Psychology and Psychiatry, University of Cambridge, Cambridge, UK. robert.rogers@psychiatry.oxford.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
